Adverse Event Reporting

SAE notification · CTCAE toxicity grading · MedWatch / CIOMS I · Causality assessment · Regulatory tracking

Total AEs (30d)

4

Serious (SAE)

2

Grade 4-5

2

Awaiting Submission

0

FDA Reported

1

Adverse Event Registry

AE-2026-0084

Subject 062

CYM-2026-001

Severe nausea and vomiting × 3 days post-dose

CTCAE: Nausea / Vomiting · Probably related · Outcome: Recovered

CTCAE Grade 3
SUBMITTED

AE-2026-0083

Subject 058

CYM-2026-001

Acute pancreatitis — hospitalized, ICU 3 days

CTCAE: Pancreatitis · Probably related · Outcome: Recovering

CTCAE Grade 4⚠ SERIOUS
REPORTED TO FDA

AE-2026-0082

Subject 142

CYM-2026-002

Stroke — left MCA, hemiparesis

CTCAE: Cerebrovascular accident · Possibly related · Outcome: Ongoing rehabilitation

CTCAE Grade 4⚠ SERIOUS
REPORTED TO IRB

AE-2026-0081

Subject 047

CYM-2026-001

Mild headache resolving with OTC analgesics

CTCAE: Headache · Possibly related · Outcome: Recovered

CTCAE Grade 1
CLOSED